Australia and New Zealand’s most promising haematology researchers now have a golden likelihood to step into the way forward for medical trials and translational medication—as a result of purposes for the celebrated ALLG HSANZ Clinical Trials Fellowship 2026 are formally open!
Jointly provided by the Australasian Leukaemia & Lymphoma Group (ALLG) and the Haematology Society of Australia and New Zealand (HSANZ), this aggressive Fellowship is designed to ignite careers in blood most cancers analysis by supporting early-profession clinicians in main modern, affected person-centered medical trials.
What Does the Fellowship Offer?
This Fellowship delivers a $70,000 funding package deal over 12 months, giving the chosen Fellow an immersive alternative to work inside ALLG’s energetic and influential medical trials ecosystem. The focus? Advancing therapies for blood cancers like leukaemia, lymphoma, and myeloma—and finally bettering affected person lives.
But that’s not all. Fellows will even:
- Collaborate with famend researchers and clinicians
- Gain experience in trial design, implementation, and affected person-reported outcomes
- Build vital networks for a protracted-time period analysis profession.
Why You Should Apply?
According to ALLG CEO Delaine Smith, this Fellowship is about greater than funding—it’s about creating future leaders in blood most cancers analysis. If you’re an early-profession clinician or researcher captivated with bettering outcomes in haematology, this could possibly be your launching pad right into a significant analysis-pushed profession.
Apply: https://www.allg.org.au/allg-hsanz-clinical-trials-fellowship-applications-now-open/
Application Deadline
The final date to apply for the ALLG HSANZ Clinical Trials Fellowship 2026 is 27 July 2025.
ALLG HSANZ Clinical Trials Fellowship 2026 FULLY FUNDED SCHOLARSHIPS SCHOLARSHIPS SCHOLARSHIPS FOR INTERNATIONAL STUDENTS UNDERGRADUATE SCHOLARSHIPS
